Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Branden Ryu, PhD
CEO at BIORCHESTRA Co., Ltd.
Speaker

Profile

Branden Ryu (Jin-hyeob Ryu), Ph.D., is the Scientific Founder, Chairman, and Chief Executive Officer of BIORCHESTRA. He earned his Ph.D. in Pathology, Immunology and Microbiology from the University of Tokyo and previously conducted research at the Wellman Center within Harvard-MIT Health Sciences and Technology. He is an inventor of BIORCHESTRA’s core proprietary technologies, including the BDDS™ CNS delivery platform and therapeutic methods. Under his leadership, BIORCHESTRA has advanced RNA therapeutics for neurological diseases, established global R&D and partnering collaborations, and built a broad intellectual property portfolio.